Further studies are required to explore these aspects but the possibility is supported by previous reports of significantly improved menstrual frequency and ovulation rate in women with PCOS treated with GLP-1R agonists and DPP-4 inhibitors [46,47,48,49,50,51,52]. Here, DPP4 is linked to polycystic ovary syndrome.